87.01 USD
↘ 4.24 (4.65%)AT CLOSE (11:59 AM EDT)
Inhibrx Biosciences, Inc. Common Stock
INBXNASDAQ • USD
87.00
↘ 0.01 (0.01%)
POST MARKET (AS OF 04:59 PM EDT)
Post Market
AS OF 04:59 PM EDT
87.00
↘ 0.01 (0.01%)
Market: CLOSED
Open?$90.08
High?$92.73
Low?$85.48
Prev. Close?$91.25
Volume?417.4K
Avg. Volume?493.4K
VWAP?$87.76
Rel. Volume?0.85x
Bid / Ask
Bid?$80.99 × 100
Ask?$94.00 × 100
Spread?$13.01
Midpoint?$87.50
Valuation & Ratios
Market Cap?1.3B
Shares Out?14.7M
Float?7.7M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?-60.69
EPS?-$8.87
Dividend?0.00%
Ex-Dividend?N/A
INBX is currently priced at $87.01. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (618.9%) and a bullish Golden Cross on the moving averages. Furthermore, INBX is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Themes
Employees
110
Market Cap
1.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?4
Momentum?50
Short Sent.?18
Piotroski F-Score?0/9Weak
Altman Z-Score?0.35Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?38.02%Squeeze Risk
Short Interest?2.9M
Days to Cover?4.5
Free Float7.7M
Avg Daily Volume654.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.46Strong
Quick Ratio?6.46Strong
Cash Ratio?6.10Strong
Debt/Equity?-8.32Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-60.69CHEAP▾
S&P97
P/S?981.95HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.7CHEAP▾
S&P97
EV/Sales?992.21HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?618.9%STRONG▾
Peers50
S&P97
ROA?-70.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-131935000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day